Streetbeat News

Stock Prices

VFC

VF Corporation (NYSE: VFC) reported a Q4 2024 adjusted EPS of $(0.32), significantly missing the analyst estimate of $0.01. The company also reported sales of $2.40 billion, slightly below the $2.41 billion estimate and a 12.40% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:08 pm

PLUS

ePlus Inc. has announced a new share repurchase plan, allowing the company to repurchase up to 1.25 million shares over the next 12 months.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:07 pm

SNPS

Synopsys has released its Q3 financial guidance, projecting adjusted EPS between $3.25 and $3.30, which is above the estimated $3.22. However, the company expects revenue to be between $1.505 billion and $1.535 billion, which is below the estimated $1.58 billion.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:07 pm

SNPS

Synopsys shares are trading lower following a Q2 earnings miss.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:06 pm

SNPS

Synopsys (NASDAQ:SNPS) reported Q2 2024 adjusted EPS of $3.00, missing the analyst estimate of $3.03. The company also reported sales of $1.455 billion, falling short of the $1.519 billion estimate. Despite the misses, sales increased by 4.30% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:06 pm

DIA

QQQ

SPY

UUP

The minutes from the May FOMC meeting indicate a prolonged period of high interest rates, countering earlier dovish signals from Fed Chair Jerome Powell. Key points include the persistence of inflation, the effectiveness of current policy, and the potential for further tightening. Financial experts highlight the impact on market fluctuations and the challenges faced by the Fed. Major indices closed lower, and the dollar gained ground.

Portfolio Pulse from Piero Cingari

May 22, 2024 | 8:05 pm

CYTK

Cytokinetics plans a proposed public offering of $500 million of common stock, with an option for underwriters to purchase an additional 15% of shares. All shares will be sold by Cytokinetics.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:03 pm

ABM

ABM has announced plans to expand its EV infrastructure capabilities to meet growing demand from clients for fleet electrification. The company has already installed over 30,000 EV ports nationwide and aims to further develop scalable solutions for commercial and public infrastructure fleets.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:02 pm

CELH

Deep-pocketed investors have shown unusual options activity for Celsius Holdings (NASDAQ:CELH), with a mix of bullish and bearish sentiments. The options activity suggests significant interest in CELH, with a price window from $45.0 to $110.0. Analysts have mixed ratings, with a consensus target price of $90.5.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 8:02 pm

ORCL

Oracle (NYSE:ORCL) has outperformed the market over the past 20 years, producing an average annual return of 12.82%. A $1000 investment in ORCL 20 years ago would be worth $10,893.87 today. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 8:01 pm